{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:30:27Z","timestamp":1794839427373,"version":"4.9.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41584-025-01305-x","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:17:51Z","timestamp":1759490271000},"page":"684-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Novel approaches to the stratified management of knee osteoarthritis"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5463-2255","authenticated-orcid":false,"given":"Nicholas R.","family":"Fuggle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2707-3959","authenticated-orcid":false,"given":"Andrea","family":"Laslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Al-Daghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Alokail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jotheeswaran Amuthavalli","family":"Thiyagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8882-9769","authenticated-orcid":false,"given":"Ewa","family":"Balkowiec-Iskra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-7815","authenticated-orcid":false,"given":"Francis","family":"Berenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie Botto-van","family":"Bemden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Joseph","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nansa","family":"Burlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3158-2106","authenticated-orcid":false,"given":"Mario M.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-5665","authenticated-orcid":false,"given":"Philip G.","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-0709","authenticated-orcid":false,"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-2437","authenticated-orcid":false,"given":"Martin","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun-il","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida K.","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-2198","authenticated-orcid":false,"given":"Nancy","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Lories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Marlovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radmila","family":"Matijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-1286","authenticated-orcid":false,"given":"Ali","family":"Mobasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sif","family":"Ormarsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C. Prieto","family":"Yerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis P.","family":"Radermecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Rannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sepodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-289X","authenticated-orcid":false,"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-422X","authenticated-orcid":false,"given":"Ren\u00e9","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-2512","authenticated-orcid":false,"given":"Nicholas C.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"1305_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100587","volume":"29\u201330","author":"A Cui","year":"2020","unstructured":"Cui, A. et al. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29\u201330, 100587 (2020).","journal-title":"EClinicalMedicine"},{"key":"1305_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/art.24021","volume":"59","author":"L Murphy","year":"2008","unstructured":"Murphy, L. et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 59, 1207\u20131213 (2008).","journal-title":"Arthritis Rheum."},{"key":"1305_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s40273-023-01296-1","volume":"41","author":"X Jin","year":"2023","unstructured":"Jin, X. et al. Economic and humanistic burden of osteoarthritis: an updated systematic review of large sample studies. Pharmacoeconomics 41, 1453\u20131467 (2023).","journal-title":"Pharmacoeconomics"},{"key":"1305_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/art.42089","volume":"74","author":"H Long","year":"2022","unstructured":"Long, H. et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol. 74, 1172\u20131183 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1305_CR5","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1136\/annrheumdis-2013-203355","volume":"73","author":"D Prieto-Alhambra","year":"2014","unstructured":"Prieto-Alhambra, D. et al. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann. Rheum. Dis. 73, 1659\u20131664 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman, R. et al. Development of criteria for the classification and reporting of osteoarthritis. classification of osteoarthritis of the knee. diagnostic and therapeutic criteria committee of the American Rheumatism Association. Arthritis Rheum. 29, 1039\u20131049 (1986).","journal-title":"Arthritis Rheum."},{"key":"1305_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/ard.2009.113100","volume":"69","author":"W Zhang","year":"2010","unstructured":"Zhang, W. et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann. Rheum. Dis. 69, 483\u2013489 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/acr.25270","volume":"76","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Evaluation of the diagnostic performance of American College of Rheumatology, EULAR, and national institute for health and clinical excellence criteria against clinically relevant knee osteoarthritis: data from the CHECK cohort. Arthritis Care Res. 76, 511\u2013516 (2024).","journal-title":"Arthritis Care Res."},{"key":"1305_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152007","volume":"55","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Diagnosis for early stage knee osteoarthritis: probability stratification, internal and external validation; data from the CHECK and OAI cohorts. Semin. Arthritis Rheum. 55, 152007 (2022).","journal-title":"Semin. Arthritis Rheum."},{"key":"1305_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41584-021-00673-4","volume":"17","author":"A Mahmoudian","year":"2021","unstructured":"Mahmoudian, A., Lohmander, L. S., Mobasheri, A., Englund, M. & Luyten, F. P. Early-stage symptomatic osteoarthritis of the knee \u2014 time for action. Nat. Rev. Rheumatol. 17, 621\u2013632 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1305_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41584-020-00523-9","volume":"17","author":"NK Arden","year":"2021","unstructured":"Arden, N. K. et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat. Rev. Rheumatol. 17, 59\u201366 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1305_CR12","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru, R. R. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 27, 1578\u20131589 (2019).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.semarthrit.2019.04.008","volume":"49","author":"O Bruy\u00e8re","year":"2019","unstructured":"Bruy\u00e8re, O. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Semin. Arthritis Rheum. 49, 337\u2013350 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"1305_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40265-022-01773-5","volume":"82","author":"N Veronese","year":"2022","unstructured":"Veronese, N. et al. Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis: a need to meet patient expectations. Drugs 82, 1347\u20131355 (2022).","journal-title":"Drugs"},{"key":"1305_CR15","unstructured":"European Medicines Agency. Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. EMA https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-used-treatment-osteoarthritis_en.pdf (2010)."},{"key":"1305_CR16","unstructured":"US Food and Drug Administration. Osteoarthritis: structural endpoints for the development of drugs, devices, and biological products for treatment \u2014 guidance for industry. fda.gov https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/osteoarthritis-structural-endpoints-development-drugs (2018)."},{"key":"1305_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152070","volume":"56","author":"JS Kim","year":"2022","unstructured":"Kim, J. S. et al. FDA\/arthritis foundation osteoarthritis drug development workshop recap: assessment of long-term benefit. Semin. Arthritis Rheum. 56, 152070 (2022).","journal-title":"Semin. Arthritis Rheum."},{"key":"1305_CR18","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2665-9913(23)00090-5","volume":"5","author":"M Englund","year":"2023","unstructured":"Englund, M. & Turkiewicz, A. Pain in clinical trials for knee osteoarthritis: estimation of regression to the mean. Lancet Rheumatol. 5, e309\u2013e311 (2023).","journal-title":"Lancet Rheumatol."},{"key":"1305_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/acr.24637","volume":"74","author":"F Berenbaum","year":"2022","unstructured":"Berenbaum, F. et al. General safety and tolerability of subcutaneous tanezumab for osteoarthritis: a pooled analysis of three randomized, placebo-controlled trials. Arthritis Care Res. 74, 918\u2013928 (2022).","journal-title":"Arthritis Care Res."},{"key":"1305_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40520-018-1098-3","volume":"31","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann, M. et al. Patients\u2019 preferences for osteoarthritis treatment: the value of stated-preference studies. Aging Clin. Exp. Res. 31, 1\u20133 (2019).","journal-title":"Aging Clin. Exp. Res."},{"key":"1305_CR21","unstructured":"The Professional Society for Health Economics and Outcomes Research. Patient-Centered Special Interest Group. https:\/\/www.ispor.org\/member-groups\/special-interest-groups\/patient-centered (2025)."},{"key":"1305_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/acr.22950","volume":"69","author":"IN Ackerman","year":"2017","unstructured":"Ackerman, I. N. et al. Preferences for disease-related education and support among younger people with hip or knee osteoarthritis. Arthritis Care Res. 69, 499\u2013508 (2017).","journal-title":"Arthritis Care Res."},{"key":"1305_CR23","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1097\/CORR.0000000000000784","volume":"477","author":"S Bunzli","year":"2019","unstructured":"Bunzli, S. et al. Misconceptions and the acceptance of evidence-based nonsurgical interventions for knee osteoarthritis. a qualitative study. Clin. Orthop. Relat. Res. 477, 1975\u20131983 (2019).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"1305_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41927-023-00340-z","volume":"7","author":"A Botto-van Bemden","year":"2023","unstructured":"Botto-van Bemden, A., Adebajo, A. O. & Fitzpatrick, C. M. Patient and public involvement in rheumatic and musculoskeletal research: an idea whose time has firmly come. BMC Rheumatol. 7, 12 (2023).","journal-title":"BMC Rheumatol."},{"key":"1305_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9","volume":"41","author":"DT Felson","year":"1998","unstructured":"Felson, D. T. & Zhang, Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 41, 1343\u20131355 (1998).","journal-title":"Arthritis Rheum."},{"key":"1305_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-0949-z","volume":"4","author":"C Parsons","year":"2015","unstructured":"Parsons, C. et al. How well do radiographic, clinical and self-reported diagnoses of knee osteoarthritis agree? Findings from the Hertfordshire cohort study. Springerplus 4, 177 (2015).","journal-title":"Springerplus"},{"key":"1305_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40520-017-0847-z","volume":"30","author":"C Parsons","year":"2018","unstructured":"Parsons, C. et al. Concordance between clinical and radiographic evaluations of knee osteoarthritis. Aging Clin. Exp. Res. 30, 17\u201325 (2018).","journal-title":"Aging Clin. Exp. Res."},{"key":"1305_CR28","doi-asserted-by":"publisher","first-page":"b2844","DOI":"10.1136\/bmj.b2844","volume":"339","author":"T Neogi","year":"2009","unstructured":"Neogi, T. et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 339, b2844 (2009).","journal-title":"BMJ"},{"key":"1305_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.joca.2023.11.008","volume":"32","author":"SL Smith","year":"2024","unstructured":"Smith, S. L. & Walsh, D. A. Osteoarthritis pain phenotypes: how best to cut the cake? Osteoarthritis Cartilage 32, 124\u2013127 (2024).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40266-025-01182-9","volume":"42","author":"D Zhang","year":"2025","unstructured":"Zhang, D., Deveza, L. A., Tan, B. Y., Dear, B. & Hunter, D. J. Antidepressants to manage osteoarthritic pain: the value of pain phenotyping. Drugs Aging 42, 183\u2013193 (2025).","journal-title":"Drugs Aging"},{"key":"1305_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/BOR.0000000000000923","volume":"35","author":"AJ Knights","year":"2023","unstructured":"Knights, A. J., Redding, S. J. & Maerz, T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr. Opin. Rheumatol. 35, 128\u2013134 (2023).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1305_CR32","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/jcm12041532","volume":"12","author":"F Pegreffi","year":"2023","unstructured":"Pegreffi, F., et al. Prevalence of sarcopenia in knee osteoarthritis: a systematic review and meta-analysis. J. Clin. Med. 12, 1532 (2023).","journal-title":"J. Clin. Med."},{"key":"1305_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/ard-2023-224997","volume":"83","author":"K Moradi","year":"2024","unstructured":"Moradi, K. et al. Erosive hand osteoarthritis and sarcopenia: data from Osteoarthritis Initiative cohort. Ann. Rheum. Dis. 83, 799\u2013806 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05098-8","volume":"24","author":"Z Jin","year":"2024","unstructured":"Jin, Z., Wang, R., Jin, L., Wan, L. & Li, Y. Causal relationship between sarcopenia with osteoarthritis and the mediating role of obesity: a univariate, multivariate, two-step mendelian randomization study. BMC Geriatr. 24, 469 (2024).","journal-title":"BMC Geriatr."},{"key":"1305_CR35","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1093\/rheumatology\/kead038","volume":"62","author":"M Pineda-Moncus\u00ed","year":"2023","unstructured":"Pineda-Moncus\u00ed, M. et al. Classification of patients with osteoarthritis through clusters of comorbidities using 633330 individuals from Spain. Rheumatology 62, 3592\u20133600 (2023).","journal-title":"Rheumatology"},{"key":"1305_CR36","first-page":"1","volume":"11","author":"T Ramazanian","year":"2023","unstructured":"Ramazanian, T., Fu, S., Sohn, S., Taunton, M. J. & Kremers, H. M. Prediction models for knee osteoarthritis: review of current models and future directions. Arch. Bone Jt Surg. 11, 1\u201311 (2023).","journal-title":"Arch. Bone Jt Surg."},{"key":"1305_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/17476348.2020.1804364","volume":"15","author":"PJ Barnes","year":"2021","unstructured":"Barnes, P. J. Endo-phenotyping of COPD patients. Expert. Rev. Respir. Med. 15, 27\u201337 (2021).","journal-title":"Expert. Rev. Respir. Med."},{"key":"1305_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40348-023-00159-1","volume":"10","author":"F Foppiano","year":"2023","unstructured":"Foppiano, F. & Schaub, B. Childhood asthma phenotypes and endotypes: a glance into the mosaic. Mol. Cell Pediatr. 10, 9 (2023).","journal-title":"Mol. Cell Pediatr."},{"key":"1305_CR39","first-page":"64","volume":"37","author":"LA Deveza","year":"2019","unstructured":"Deveza, L. A., Nelson, A. E. & Loeser, R. F. Phenotypes of osteoarthritis: current state and future implications. Clin. Exp. Rheumatol. 37, 64\u201372 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1305_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41584-024-01126-4","volume":"20","author":"A Mobasheri","year":"2024","unstructured":"Mobasheri, A. & Loeser, R. Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development. Nat. Rev. Rheumatol. 20, 525\u2013526 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1305_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bcp.2019.02.037","volume":"165","author":"WE Van Spil","year":"2019","unstructured":"Van Spil, W. E., Kubassova, O., Boesen, M., Bay-Jensen, A. C. & Mobasheri, A. Osteoarthritis phenotypes and novel therapeutic targets. Biochem. Pharmacol. 165, 41\u201348 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"1305_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.1975.03250020031020","volume":"232","author":"GE Ehrlich","year":"1975","unstructured":"Ehrlich, G. E. Osteoarthritis beginning with inflammation. Definitions and correlations. JAMA 232, 157\u2013159 (1975).","journal-title":"JAMA"},{"key":"1305_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","volume":"21","author":"F Berenbaum","year":"2013","unstructured":"Berenbaum, F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 21, 16\u201321 (2013).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/BOR.0000000000000567","volume":"31","author":"A Mobasheri","year":"2019","unstructured":"Mobasheri, A. et al. Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes. Curr. Opin. Rheumatol. 31, 80\u201389 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1305_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson, W. H. et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 580\u2013592 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1305_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035101","volume":"10","author":"EM van Helvoort","year":"2020","unstructured":"van Helvoort, E. M. et al. Cohort profile: the applied public-private research enabling osteoarthritis clinical headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers. BMJ Open 10, e035101 (2020).","journal-title":"BMJ Open"},{"key":"1305_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7326\/M20-0527","volume":"173","author":"M Schieker","year":"2020","unstructured":"Schieker, M. et al. Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 173, 509\u2013515 (2020).","journal-title":"Ann. Intern. Med."},{"key":"1305_CR48","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.20575.1","volume":"8","author":"A Mobasheri","year":"2019","unstructured":"Mobasheri, A. et al. Recent advances in understanding the phenotypes of osteoarthritis. F1000Res. 8, F1000 (2019).","journal-title":"F1000Res."},{"key":"1305_CR49","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/acr.24340","volume":"73","author":"JE Collins","year":"2021","unstructured":"Collins, J. E., Neogi, T. & Losina, E. Trajectories of structural disease progression in knee osteoarthritis. Arthritis Care Res. 73, 1354\u20131362 (2021).","journal-title":"Arthritis Care Res."},{"key":"1305_CR50","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1148\/radiol.14140991","volume":"274","author":"FW Roemer","year":"2015","unstructured":"Roemer, F. W. et al. Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year? Radiology 274, 810\u2013820 (2015).","journal-title":"Radiology"},{"key":"1305_CR51","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.joca.2014.12.024","volume":"23","author":"MA Karsdal","year":"2015","unstructured":"Karsdal, M. A. et al. OA phenotypes, rather than disease stage, drive structural progression \u2014 identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA. Osteoarthritis Cartilage 23, 550\u2013558 (2015).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR52","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1002\/art.39731","volume":"68","author":"JE Collins","year":"2016","unstructured":"Collins, J. E. et al. Semiquantitative imaging biomarkers of knee osteoarthritis progression: data from the foundation for the national institutes of health osteoarthritis biomarkers consortium. Arthritis Rheumatol. 68, 2422\u20132431 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1305_CR53","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/annrheumdis-2020-217363","volume":"79","author":"K Bacon","year":"2020","unstructured":"Bacon, K., LaValley, M. P., Jafarzadeh, S. R. & Felson, D. Does cartilage loss cause pain in osteoarthritis and if so, how much? Ann. Rheum. Dis. 79, 1105\u20131110 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","volume":"13","author":"X Ayral","year":"2005","unstructured":"Ayral, X., Pickering, E. H., Woodworth, T. G., Mackillop, N. & Dougados, M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis \u2014 results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13, 361\u2013367 (2005).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR55","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1136\/ard.2011.150243","volume":"70","author":"FW Roemer","year":"2011","unstructured":"Roemer, F. W. et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann. Rheum. Dis. 70, 1804\u20131809 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jmri.28223","volume":"57","author":"S Ramezanpour","year":"2023","unstructured":"Ramezanpour, S. et al. Impact of sustained synovitis on knee joint structural degeneration: 4-Year MRI data from the osteoarthritis initiative. J. Magn. Reson. Imaging 57, 153\u2013164 (2023).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1305_CR57","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/ard.2008.099564","volume":"69","author":"PG Conaghan","year":"2010","unstructured":"Conaghan, P. G. et al. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann. Rheum. Dis. 69, 644\u2013647 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00008","volume":"139","author":"DT Felson","year":"2003","unstructured":"Felson, D. T. et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann. Intern. Med. 139, 330\u2013336 (2003).","journal-title":"Ann. Intern. Med."},{"key":"1305_CR59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/ard.2010.131904","volume":"70","author":"E Yusuf","year":"2011","unstructured":"Yusuf, E., Kortekaas, M. C., Watt, I., Huizinga, T. W. & Kloppenburg, M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann. Rheum. Dis. 70, 60\u201367 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR60","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.joca.2020.05.008","volume":"28","author":"FW Roemer","year":"2020","unstructured":"Roemer, F. W., Collins, J. E., Neogi, T., Crema, M. D. & Guermazi, A. Association of knee OA structural phenotypes to risk for progression: a secondary analysis from the foundation for national institutes of health osteoarthritis biomarkers study (FNIH). Osteoarthritis Cartilage 28, 1220\u20131228 (2020).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR61","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/ard.2008.096834","volume":"68","author":"FW Roemer","year":"2009","unstructured":"Roemer, F. W. et al. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann. Rheum. Dis. 68, 1461\u20131465 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR62","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/art.21789","volume":"54","author":"DJ Hunter","year":"2006","unstructured":"Hunter, D. J. et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum. 54, 1529\u20131535 (2006).","journal-title":"Arthritis Rheum."},{"key":"1305_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.crad.2022.08.149","volume":"78","author":"C McCague","year":"2023","unstructured":"McCague, C. et al. Introduction to radiomics for a clinical audience. Clin. Radiol. 78, 83\u201398 (2023).","journal-title":"Clin. Radiol."},{"key":"1305_CR64","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.42915","volume":"76","author":"S Li","year":"2024","unstructured":"Li, S. et al. Integrating radiomics and neural networks for knee osteoarthritis incidence prediction. Arthritis Rheumatol. 76, 1377\u20131386 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1305_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111826","volume":"181","author":"S Gao","year":"2024","unstructured":"Gao, S. et al. Cartilage T2 mapping-based radiomics in knee osteoarthritis research: Status, progress and future outlook. Eur. J. Radiol. 181, 111826 (2024).","journal-title":"Eur. J. Radiol."},{"key":"1305_CR66","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/annrheumdis-2020-217160","volume":"80","author":"MA Bowes","year":"2021","unstructured":"Bowes, M. A. et al. Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative. Ann. Rheum. Dis. 80, 502\u2013508 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR67","doi-asserted-by":"publisher","first-page":"1759720x2110403","DOI":"10.1177\/1759720X211040300","volume":"13","author":"JC Rousseau","year":"2021","unstructured":"Rousseau, J. C., Chapurlat, R. & Garnero, P. Soluble biological markers in osteoarthritis. Ther. Adv. Musculoskelet. Dis. 13, 1759720x211040300 (2021).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"1305_CR68","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1016\/j.joca.2017.02.468","volume":"25","author":"C Kjelgaard-Petersen","year":"2017","unstructured":"Kjelgaard-Petersen, C. et al. Establishment of a human synovium and cartilage co-culture. Osteoarthritis Cartilage 25, S276\u2013S277 (2017).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR69","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","volume":"76","author":"VB Kraus","year":"2017","unstructured":"Kraus, V. B. et al. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers consortium. Ann. Rheum. Dis. 76, 186\u2013195 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR70","doi-asserted-by":"crossref","unstructured":"Hosmer, D. W. Jr., Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression (Wiley, 2013).","DOI":"10.1002\/9781118548387"},{"key":"1305_CR71","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.joca.2019.12.012","volume":"28","author":"P Garnero","year":"2020","unstructured":"Garnero, P., Sornay-Rendu, E. & Chapurlat, R. The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort. Osteoarthritis Cartilage 28, 468\u2013474 (2020).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR72","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3899\/jrheum.2023-0684","volume":"51","author":"P Garnero","year":"2024","unstructured":"Garnero, P., Gineyts, E., Rousseau, J. C., Sornay-Rendu, E. & Chapurlat, R. D. Plasma cartilage acidic protein 1 measured by ELISA is associated with the progression to total joint replacement in postmenopausal women. J. Rheumatol. 51, 176\u2013180 (2024).","journal-title":"J. Rheumatol."},{"key":"1305_CR73","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.joca.2015.05.015","volume":"23","author":"JC Rousseau","year":"2015","unstructured":"Rousseau, J. C., Sornay-Rendu, E., Bertholon, C., Garnero, P. & Chapurlat, R. Serum periostin is associated with prevalent knee osteoarthritis and disease incidence\/progression in women: the OFELY study. Osteoarthritis Cartilage 23, 1736\u20131742 (2015).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13075-019-2086-5","volume":"22","author":"JC Rousseau","year":"2020","unstructured":"Rousseau, J. C. et al. Association of circulating microRNAs with prevalent and incident knee osteoarthritis in women: the OFELY study. Arthritis Res. Ther. 22, 2 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"1305_CR75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13075-023-03253-x","volume":"26","author":"SP Yu","year":"2024","unstructured":"Yu, S. P. et al. Association of biochemical markers with bone marrow lesion changes on imaging-data from the foundation for the national institutes of health osteoarthritis biomarkers consortium. Arthritis Res. Ther. 26, 30 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"1305_CR76","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.joca.2016.01.156","volume":"24","author":"VB Kraus","year":"2016","unstructured":"Kraus, V. B., Catterall, J., Soderblom, E., Moseley, M. A. & Suchindran, S. Development of a serum biomarker panel highly predictive of a knee osteoarthritis diagnosis. Osteoarthritis Cartilage 24, S72 (2016).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5095","volume":"9","author":"K Zhou","year":"2023","unstructured":"Zhou, K. et al. A \u201cbest-in-class\u201d systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression. Sci. Adv. 9, eabq5095 (2023).","journal-title":"Sci. Adv."},{"key":"1305_CR78","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj6814","volume":"10","author":"VB Kraus","year":"2024","unstructured":"Kraus, V. B. et al. An osteoarthritis pathophysiological continuum revealed by molecular biomarkers. Sci. Adv. 10, eadj6814 (2024).","journal-title":"Sci. Adv."},{"key":"1305_CR79","unstructured":"Council Conclusions on Personalised Medicine for Patients. European Commission. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A52015XG1217%2801%29&qid=1753365910739 (2015)."},{"key":"1305_CR80","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jez.1400090405","volume":"9","author":"RG Harrison","year":"1910","unstructured":"Harrison, R. G. The outgrowth of the nerve fiber as a mode of protoplasmic movement. J. Exp. Zool. 9, 787\u2013846 (1910).","journal-title":"J. Exp. Zool."},{"key":"1305_CR81","doi-asserted-by":"publisher","DOI":"10.3791\/59676","author":"D Lee","year":"2019","unstructured":"Lee, D., Erickson, A., Dudley, A. T. & Ryu, S. A microfluidic platform for stimulating chondrocytes with dynamic compression. J. Vis. Exp. https:\/\/doi.org\/10.3791\/59676 (2019).","journal-title":"J. Vis. Exp."},{"key":"1305_CR82","first-page":"61","volume":"33","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Cartilage-on-a-chip with magneto-mechanical transformation for osteoarthritis recruitment. Bioact. Mater. 33, 61\u201368 (2024).","journal-title":"Bioact. Mater."},{"key":"1305_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2019.100023","volume":"4","author":"J Rosser","year":"2019","unstructured":"Rosser, J. et al. Microfluidic nutrient gradient-based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model. Mater. Today Bio. 4, 100023 (2019).","journal-title":"Mater. Today Bio."},{"key":"1305_CR84","doi-asserted-by":"publisher","DOI":"10.1177\/19476035241277654","author":"M Pasztorek","year":"2024","unstructured":"Pasztorek, M., et al. Exploring osteoarthritis dynamics: patient-specific cartilage samples in an organ-on-a-chip model. Cartilage https:\/\/doi.org\/10.1177\/19476035241277654 (2024).","journal-title":"Cartilage"},{"key":"1305_CR85","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","volume":"26","author":"C McCabe","year":"2008","unstructured":"McCabe, C., Claxton, K. & Culyer, A. J. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 26, 733\u2013744 (2008).","journal-title":"Pharmacoeconomics"},{"key":"1305_CR86","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/archinternmed.2009.136","volume":"169","author":"E Losina","year":"2009","unstructured":"Losina, E. et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch. Intern. Med. 169, 1113\u20131121 (2009). discussion 21\u20132.","journal-title":"Arch. Intern. Med."},{"key":"1305_CR87","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.joca.2016.07.013","volume":"24","author":"K Mari","year":"2016","unstructured":"Mari, K., D\u00e9gieux, P., Mistretta, F., Guillemin, F. & Richette, P. Cost utility modeling of early vs late total knee replacement in osteoarthritis patients. Osteoarthritis Cartilage 24, 2069\u20132076 (2016).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR88","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.joca.2020.10.002","volume":"29","author":"DR Mazzei","year":"2021","unstructured":"Mazzei, D. R. et al. Are education, exercise and diet interventions a cost-effective treatment to manage hip and knee osteoarthritis? A systematic review. Osteoarthritis Cartilage 29, 456\u2013470 (2021).","journal-title":"Osteoarthritis Cartilage"},{"key":"1305_CR89","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40258-022-00717-0","volume":"20","author":"J Shi","year":"2022","unstructured":"Shi, J. et al. Cost effectiveness of pharmacological management for osteoarthritis: a systematic review. Appl. Health Econ. Health Policy 20, 351\u2013370 (2022).","journal-title":"Appl. Health Econ. Health Policy"},{"key":"1305_CR90","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/rheumatology\/keac415","volume":"62","author":"IA Szilagyi","year":"2023","unstructured":"Szilagyi, I. A. et al. Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression. Rheumatology 62, 1286\u20131295 (2023).","journal-title":"Rheumatology"},{"key":"1305_CR91","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-024-03332-7","volume":"26","author":"SS Groen","year":"2024","unstructured":"Groen, S. S. et al. Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis. Arthritis Res. Ther. 26, 107 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"1305_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ard.7.1.1","volume":"7","author":"RM Stecher","year":"1948","unstructured":"Stecher, R. M. Heberden\u2019s nodes: the clinical characteristic of osteo-arthritis of the fingers. Ann. Rheum. Dis. 7, 1\u20138 (1948).","journal-title":"Ann. Rheum. Dis."},{"key":"1305_CR93","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40520-022-02312-8","volume":"35","author":"H Long","year":"2023","unstructured":"Long, H., Cao, R., Yin, H., Yu, F. & Guo, A. Associations between obesity, diabetes mellitus, and cardiovascular disease with progression states of knee osteoarthritis (KOA). Aging Clin. Exp. Res. 35, 333\u2013340 (2023).","journal-title":"Aging Clin. Exp. Res."},{"key":"1305_CR94","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40520-024-02714-w","volume":"36","author":"G Herrero-Beaumont","year":"2024","unstructured":"Herrero-Beaumont, G. et al. Systemic osteoarthritis: the difficulty of categorically naming a continuous condition. Aging Clin. Exp. Res. 36, 45 (2024).","journal-title":"Aging Clin. Exp. Res."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01305-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:02:17Z","timestamp":1761177737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01305-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":94,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01305-x","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"5 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.C., N.A-D., M.A., J.A.T., J.-J.B., N.B., E.C., M.M.R, C.C., G.I.I., A.K., N.L., S.M., R.M., S.O., M.C.P.Y., R.P.R., F.R., B.S., S.S., C.T., A.L. and E.B.I. declare no competing interests. N.R.F. has received speaker fees and honoraria from UCB and Viatris and travel bursaries from Pfizer and Eli Lilly. F.B. reports personal fees from 4\u2009P Pharma, 4Moving Biotech, Grunenthal, GSK, Heel, Nordic Bioscience, Novartis, Servier, TRB Chemedica and Viatris. O.B. has received consulting or lecture fees from Amgen, Aptissen, Biophytis, IBSA, Mylan, Novartis, Nutricia, Orifarm, Sanofi, UCB and Viatris. P.G.C. has performed consultancies or speakers bureaus for Eli Lilly, Eupraxia, Formation Bio, Galapagos, Genascence, GSK, Grunenthal, Janssen, Kolon TissueGene, Levicept, Medipost, Moebius, Novartis, Pacira, Sandoz and Stryker & Takeda. E.M.D. reports honoraria from UCB, Viatris and Pfizer. M.E. reports consultancy for Gr\u00fcnenthal Sweden AB and Key2Compliance. I.K.H. reports personal fees from Novartis, AbbVie, Gr\u00fcnenthal and GSK during the past 36 months. M.H. reports in the past 36 months research grants (paid to institution) from Radius Heath and Angelini Pharma, as well as lecture or consulting fees (all paid to institution) from Grunenthal, Pfizer, Mylan Pharmaceuticals and IBSA. Leuven R&D\u00a0and the valorization division of KU Leuven, and\u00a0has received speaker fees and honoraria from AbbVie, Amgen, Galapagos, Biosplice (formerly Samumed), Biocon (formerly Viatris), Eli-Lilly, Novartis and UCB on behalf of R.L. A.M. has received speaker fees and honoraria from HALEON, Gr\u00fcnenthal, Kolon TissueGene, Kolon Life Science Cluster, Aptissen SA, California Institute for Regenerative Medicine (CIRM), Sanofi, Sanofi Consumer Healthcare, GSK, Novartis, Pfizer, Viatris, Contura, Enlivex, Orion Corporation, Pluri, Pacira Biosciences, Laboratoires Expanscience and Synartro Ampio Pharmaceuticals. N.V. reports personal fees from IBSA, Mylan, Viatris, Sanofi, Nestl\u00e8 and Fidia outside of the submitted work. R.R. has received fees for advisory board or lectures from Abiogen, Effryx and Theramex. J-Y.R. reports consulting fees or paid advisory boards for IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Faes Pharma, Rejuvenate Biomed, Samumed, Teva, Theramex, Pfizer and\u00a0Mithra Pharmaceuticals, lecture fees when speaking at the invitation of sponsor for IBSA-Genevrier, Mylan, Cniel, Dairy Research Council, Nutricia, Danone and\u00a0Agnovos, and grant support from IBSA-Genevrier, Mylan, Cniel, Radius Health and TRB. N.C.H reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, UCB, Kyowa Kirin, Servier, Shire, Consilient Healthcare, Theramex and Internis Pharma.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}